NCT01509027

Brief Summary

Hyperphosphatemia is a common and severe complication in chronic kidney disease patients treated with hemodialysis. A phosphate restricted diet and oral phosphate binders are the cornerstones in the prevention and treatment of this complication. However, noncompliance is an prevalent problem resulting in poorly controled hyperphosphatemia in a substantial proportion of hemodialysis patients. The present study aims at identifying risk factors for non compliance and also test the hypothesis that compliance can be improved by education patients on the consequences of hyperphosphatemia and the importance of diet and phosphate binder therapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

January 9, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 12, 2012

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

May 30, 2012

Status Verified

January 1, 2012

Enrollment Period

5 months

First QC Date

January 9, 2012

Last Update Submit

May 29, 2012

Conditions

Keywords

hemodialysishyperphoshatemiacompliance

Outcome Measures

Primary Outcomes (2)

  • compliance

    impact of education (by DVD and interview with dietician)on compliance with phosphorus restricted diet and phosphate binder therapy

    baseline and after intervention

  • serum phosphate levels

    impact of education (by DVD and interview with dietician) on serum phosphate levels

    baseline and after intervention

Secondary Outcomes (1)

  • risk factors of noncompliance

    baseline

Study Arms (3)

Education by DVD and dietician

ACTIVE COMPARATOR

Information on detrimental conseqences of hyperphosphatemia is presented on DVD and individual dietary counseling is given by dieticican

Behavioral: Education by DVD and dietician

Education by unpersonalised DVD

ACTIVE COMPARATOR

Information on detrimental consequences of hyperphosphatemia is presented on DVD

Behavioral: education by DVD

Standard Care

PLACEBO COMPARATOR

standard care

Behavioral: Standard care

Interventions

Information on detrimental conseqences of hyperphosphatemia is presented on DVD

Education by unpersonalised DVD
Standard careBEHAVIORAL

standard care

Standard Care

Information on detrimental conseqences of hyperphosphatemia is presented on DVD and individual dietary counseling is given by dieticican

Education by DVD and dietician

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • prevalent (\>3months) hemodialysis patients
  • aged \> 18 years
  • informed consent

You may not qualify if:

  • decreased consciousness
  • unstable
  • medical contraindication for phosphorus restricted diet or phsophate binder therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Leuven

Leuven, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, ChronicPatient Compliance

Interventions

Standard of CareNutritionists

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationHealth PersonnelHealth Care Facilities Workforce and Services

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2012

First Posted

January 12, 2012

Study Start

January 1, 2012

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

May 30, 2012

Record last verified: 2012-01

Locations